Indication:
The treatment of chronic hepatitis Bvirus infection in adults with evidence of active viral replication and either evidence of persistent elevation in serum aminotransferases (ALT or AST) or histologically active disease. This indication is based on histologic, virologic, biochemical, and serologic responses after one year of treatment in nucleoside-treatment-native and lamivudine-resistant adult patients with HBeAg-positive or HBeAg negative chronic HBV infection with compensated liver disease and on more limited data in adult patients with HIV/HBV co-infection who have received prior lamivudine therapy.
Dosage Forms:
Each tablet contains Entecavir USP……0.5mg